Investment Opportunity in Sustainable Nitrogen Company
- Equity investors interested in up to 20% equity in Series A investment round closing 31 October 2021 (minimum investment is $250K). Board seat available for strategic investor.
Challenge: The use of synthetic fertilisers has revolutionised agriculture and enabled significant increases in crops yield. However, agricultural industries are now looking for fertilisers that:
- do not adversely impact soils, waterways and the broader environment
- do not contribute to greenhouse gas emissions.
In addition, public policy and government regulation are increasingly focused on improved environmental outcomes relating to global food and fibre production. This, combined with consumers and companies in the food supply chain demanding greater transparency and accountability, is driving producers to seek alternate solutions to improve profitability and demonstrate their sustainability on farm.
Current Opportunity: Kreotec, a Thinkbio product uses bacteria to deliver a sustainable form of nitrogen to crops. This increased nitrogen delivery enables growers to reduce synthetic nitrogen fertiliser use by up to 40%, leading to a reduction of input cost to growers, currently saving between $20- $40/ha, improved soil health and increased yields with less adverse environmental impact.
Thinkbio currently has product in market and commercial sales in three countries including Australia, USA and Italy. Product registration and validation trials with local distribution partners are currently in progress in another five countries, being Germany, Spain, Turkey, Morocco and Canada. Kreotec is also in trials with two global distributors seeking partnership opportunities.
Potential Other Applications: Thinkbio is in the process of developing Kreotec for smallholder farmers.
Express interest by
Project led by
Looking for engagement?
Showcase your commercialisation opportunity today.
Talk to our team to discuss how growAG. can connect your innovation to industry.
Have questions? Find answers to our most frequently asked questions on research projects, commercial opportunities, organisations and more.